H. Mukawa

发表

Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease.

K. Okumura, T. Murohara, Y. Numaguchi, 2003, American heart journal.

Pressure overload per se rather than cardiac angiotensin converting enzyme activity may be important in the development of rat cardiac hypertrophy

K. Okumura, T. Hayakawa, I. Morishima, 1997, Journal of hypertension.

Impact of angiographic peri-stent contrast staining (PSS) on late adverse events after sirolimus-eluting stent implantation: an observation from the multicenter j-Cypher registry PSS substudy

H. Tamekiyo, H. Fujita, Takeshi Kimura, 2014, Cardiovascular Intervention and Therapeutics.

by Atrial Natriuretic Peptide Renal Protective Effects and the Prevention of Contrast-Induced Nephropathy

T. Murohara, Y. Numaguchi, Y. Morita, 2011 .

Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide.

K. Okumura, T. Murohara, Y. Numaguchi, 2009, Journal of the American College of Cardiology.

P Contrast-Induced Nephropathy Renal Protective Effects and the Prevention of Contrast-Induced Nephropathy by Atrial Natriuretic Peptide

K. Okumura, T. Murohara, Y. Numaguchi, 2022 .

Plasma C‐reactive protein predicts left ventricular remodeling and function after a first acute anterior wall myocardial infarction treated with coronary angioplasty: Comparison with brain natriuretic peptide

K. Okumura, I. Morishima, H. Tsuboi, 2002, Clinical cardiology.

Risk stratification of patients with prior myocardial infarction and advanced left ventricular dysfunction by gated myocardial perfusion SPECT imaging

K. Okumura, T. Murohara, Ryuichiro Murakami, 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Outcomes of the largest multi-center trial stratified by the presence of diabetes mellitus comparing sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in patients with coronary artery disease. The Japan drug-eluting stents evaluation: a randomized trial (J-DESsERT)

H. Fujita, Y. Matsuyama, S. Suwa, 2015, Cardiovascular Intervention and Therapeutics.

A case of fulminant myocarditis associated with novel N1H1 influenza successfully treated by percutaneous cardiopulmonary support system.

Y. Kanzaki, H. Nagai, I. Morishima, 2010, Journal of cardiology cases.

CorrespondenceLetter to the EditorReply

K. Okumura, T. Murohara, Y. Numaguchi, 2010 .

Angiotensin II type 2 receptor blockade partially negates antihypertrophic effects of type 1 receptor blockade on pressure-overload rat cardiac hypertrophy.

K. Okumura, H. Matsui, Y. Toki, 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

Three-year follow-up outcomes of SES and PES in a randomized controlled study stratified by the presence of diabetes mellitus: J-DEsSERT trial.

H. Fujita, Y. Matsuyama, S. Suwa, 2016, International journal of cardiology.

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.

A1 The angiotensin II type 2 receptor may partly be involved in antihypertrophic effects exerted by the type 1 receptor antagonist in hypertensive rat

K. Okumura, A. Shimauchi, Y. Toki, 1997 .

Nitroglycerin-induced aortic relaxation mediated by calcium-activated potassium channel is markedly diminished in hypertensive rats.

K. Okumura, Y. Numaguchi, H. Matsui, 1998, Life Science.

Asymptomatic Brugada Syndrome Associated with Postural Orthostatic Tachycardia Syndrome:

I. Morishima, H. Tsuboi, T. Sone, 2004, Pacing and clinical electrophysiology : PACE.

Acute myocardial infarction caused by spontaneous postpartum coronary artery dissection

K. Takagi, I. Morishima, H. Tsuboi, 2007, Nature Clinical Practice Cardiovascular Medicine.

Follow‐up X Rays Play a Key Role in Detecting Implantable Cardioverter Defibrillator Lead Fracture:

I. Morishima, H. Tsuboi, T. Sone, 2003, Pacing and clinical electrophysiology : PACE.

Adenosine‐Sensitive Focal Reentrant Atrial Tachycardia Originating From the Mitral Annulus‐Aorta Junction

I. Morishima, T. Sone, H. Mukawa, 2008 .

Rescue pulmonary vein isolation for hemodynamically unstable atrial fibrillation storm in a patient with an acute extensive myocardial infarction

I. Morishima, T. Sone, H. Mukawa, 2012, BMC Cardiovascular Disorders.

Novel Technique to Facilitate Defibrillator Lead Implantation via Cephalic Vein Cutdown by Means of a Reference Catheter and a Specially Designed Long Sheath

I. Morishima, T. Sone, H. Mukawa, 2005 .

The Glu298Asp polymorphism in endothelial nitric oxide synthase gene is associated with coronary in-stent restenosis.

K. Okumura, T. Hayakawa, T. Sone, 2002, International journal of cardiology.

Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats

Kazunori Hayashi, Takayuki Ito, Tetsuo Hayakawa, 1998 .

Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.

K. Okumura, T. Hayakawa, T. Sone, 2002, Circulation journal : official journal of the Japanese Circulation Society.

Effect of Optimal Medical Therapy Before Procedures on Outcomes in Coronary Patients Treated With Drug-Eluting Stents.

H. Fujita, Y. Matsuyama, S. Suwa, 2016, The American journal of cardiology.

Restoring the Recurrent Extrusion of the Subcutaneously Implanted Defibrillator by Means of Subpectoral Replacement: The Benefits of Subpectoral Implantation in the Current ICD Era

I. Morishima, H. Mukawa, Hisakazu Kato, 2005 .

Short-term treatment with prostaglandin E1 analogue has long-term preventive effects on intimal thickening in balloon-injured rat carotid arteries.

K. Okumura, T. Hayakawa, Y. Numaguchi, 1998, Prostaglandins & other lipid mediators.

Blood purification therapy in cardiovascular diseases

I. Morishima, T. Sone, H. Mukawa, 2004 .

Presence of myocardial hypoenhancement on multidetector computed tomography after primary percutaneous coronary intervention in acute myocardial infarction predicts poor prognosis.

K. Okumura, T. Murohara, I. Morishima, 2015, International journal of cardiology.

Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data

Pedro F. Campos, Roger A. Nadeau, Jonathan B Sumner, 2021, BMJ.

Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.

K. Okumura, T. Hayakawa, I. Morishima, 2000, Journal of the American College of Cardiology.

Relation of a Common Methylenetetrahydrofolate Reductase Mutation and Plasma Homocysteine With Intimal Hyperplasia After Coronary Stenting

K. Okumura, T. Hayakawa, T. Sone, 2001, Circulation.

Increased oxysterol contents in diabetic rat hearts: their involvement in diabetic cardiomyopathy.

K. Okumura, H. Matsui, Y. Toki, 1997, The Canadian journal of cardiology.

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.

Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats.

K. Okumura, T. Hayakawa, I. Morishima, 1998, Life sciences.

Effect of Optimal Medical Therapy Before Procedures on Outcomes in Coronary Patients Treated With Drug-Eluting Stents.

H. Fujita, Y. Matsuyama, S. Suwa, 2016, The American journal of cardiology.

Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide.

K. Okumura, T. Murohara, Y. Numaguchi, 2009, Journal of the American College of Cardiology.

Effect of quinapril on intimal hyperplasia after coronary stenting as assessed by intravascular ultrasound.

K. Okumura, T. Suzuki, T. Sone, 2001, The American journal of cardiology.